Population attributable risks of esophageal and gastric cancers

被引:521
|
作者
Engel, LS
Chow, WH
Vaughan, TL
Gammon, MD
Risch, HA
Stanford, JL
Schoenberg, JB
Mayne, ST
Dubrow, R
Rotterdam, H
West, AB
Blaser, M
Blot, WJ
Gail, MH
Fraumeni, JF
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98195 USA
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[4] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
[5] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
[6] New Jersey Dept Hlth & Senior Serv, Canc Epidemiol Serv, Trenton, NJ USA
[7] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA
[8] NYU, Dept Pathol, New York, NY 10016 USA
[9] NYU, Sch Med, Dept Med, New York, NY USA
[10] Int Epidemiol Inst, Rockville, MD USA
关键词
D O I
10.1093/jnci/djg047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several risk factors have been identified for esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and noncardia gastric adenocarcinoma, but no study has comprehensively examined their contributions to the cancer burden in the general population. Herein, we estimate the population attributable risks (PARs) for various risk factors observed in a multicenter population-based case-control study. Methods: We calculated PARs by using 293 patients with esophageal adenocarcinoma, 261 with gastric cardia adenocarcinoma, 221 with esophageal squamous cell carcinoma, 368 with noncardia gastric adenocarcinoma, and 695 control subjects. We included smoking for all four tumor types and Helicobacter pylori infection for noncardia gastric adenocarcinoma as established causal risk factors as well as several other factors for which causality is under evaluation. Results: Ever smoking, body mass index above the lowest quartile, history of gastroesophageal reflux, and low fruit and vegetable consumption accounted for 39.7% (95% confidence interval [CI] = 25.6% to 55.8%),41.1% (95% CI = 23.8% to 60.9%), 29.7% (95% CI = 19.5% to 42.3%), and 15.3% (95% CI = 5.8% to 34.6%) of esophageal adenocarcinomas, respectively, with a combined PAR of 78.7% (95% CI = 66.5% to 87.3%). Ever smoking and body mass index above the lowest quartile were responsible for 45.2% (95% CI = 31.3% to 59.9%) and 19.2% (95% CI = 4.9% to 52.0%) of gastric cardia adenocarcinomas, respectively, with a combined PAR of 56.2% (95% CI = 38.1% to 72.8%). Ever smoking, alcohol consumption, and low fruit and vegetable consumption accounted for 56.9% (95% Cl = 36.6% to 75.1%), 72.4% (95% CI = 53.3% to 85.8%), and 28.7% (95% CI = 11.1% to 56.5%) of esophageal squamous cell carcinomas, respectively, with a combined PAR of 89.4% (95% CI = 79.1% to 95.0%). Ever smoking, history of gastric ulcers, nitrite intake above the lowest quartile, and H. pylori infection were responsible for 18.3% (95% CI = 6.5% to 41.8%), 9.7% (95% CI = 5.4% to 16.8%), 40.7% (95% CI = 23.4% to 60.7%), and 10.4% (95% CI = 0.3% to 79.6%) of noncardia gastric adenocrcinomas, respectively, with a combined PAR of 59.0% (95% CI = 16.2% to 91.4%). Conclusion: In this population, a few known risk factors account for a majority of esophageal and gastric cancers. These results suggest that the incidence of these cancers may be decreased by reducing the prevalence of smoking, gastroesophageal reflux, and being overweight and by increasing the consumption of fruits and vegetables.
引用
收藏
页码:1404 / 1413
页数:10
相关论文
共 50 条
  • [41] Circulating tumor cells of esophageal and gastric cancers.
    Erkizan, Hayriye Verda
    Wadleigh, Robert G.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] PROSPECTIVE STUDY OF DIABETES AND THE RISK OF GASTRIC AND ESOPHAGEAL CANCERS
    Lin, S-W
    Freedman, N. D.
    Hollenbeck, A. R.
    Abnet, C. C.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S60 - S60
  • [43] The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
    Ren, Zhenxing
    Rajani, Cynthia
    Jia, Wei
    CANCERS, 2021, 13 (04) : 1 - 24
  • [44] Endoscopic mucosal resection for esophageal and gastric mucosal cancers
    Inoue, H
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1998, 12 (05): : 355 - 359
  • [45] Expression of manganese superoxide dismutase in esophageal and gastric cancers
    Ryo Izutani
    Satoshi Asano
    Motohiro Imano
    Daisuke Kuroda
    Michio Kato
    Harumasa Ohyanagi
    Journal of Gastroenterology, 1998, 33 : 816 - 822
  • [46] The Relationship Between Gastric and Esophageal Cancers in Italy Response
    Derakhshan, Mohammad H.
    Arnold, Melina
    Brewster, David H.
    Going, James J.
    Mitchell, David R.
    Forman, David
    McColl, Kenneth E. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1202 - 1203
  • [47] Expression of manganese superoxide dismutase in esophageal and gastric cancers
    Izutani, R
    Asano, S
    Imano, M
    Kuroda, D
    Kato, M
    Ohyanagi, H
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (06) : 816 - 822
  • [48] Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
    Dhakras, Purabi
    Uboha, Nataliya
    Horner, Vanessa
    Reinig, Erica
    Matkowskyj, Kristina A.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [49] Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers
    Zhang, Xiaoli
    Pan, Zui
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 206 - 214
  • [50] INTEREST AND LIMITATION OF CEA RADIOIMMUNOASSAY IN ESOPHAGEAL AND GASTRIC CANCERS
    CHATAL, JF
    DEDIEU, PR
    LEMEVEL, BP
    HELARY, J
    GUIHARD, D
    SALARD, JL
    BULLETIN DU CANCER, 1976, 63 (04) : 531 - 540